Status:
UNKNOWN
Assessment of End-tidal Carbon Dioxide Levels in Respiratory Disease
Lead Sponsor:
National Hospital Organization Minami Kyoto Hospital
Conditions:
Respiratory Disease
Eligibility:
All Genders
20+ years
Brief Summary
The investigators aim to evaluate the correlation between PetCO2, PaCO2, and PtcCO2 in patients with respiratory diseases. The investigators also evaluate the correlation between PetCO2, PaCO2, and Pt...
Detailed Description
Partial pressure of carbon dioxide(PCO2) is mainly evaluated by partial pressure of arterial carbon dioxide (PaCO2), and is used as an index for prognosis and NPPV introduction in chronic respiratory ...
Eligibility Criteria
Inclusion
- Subjects with respiratory disorder.
- Subjects who are clinically stable for the last 2 weeks
Exclusion
- Subjects who required treatment with antibacterial agents or oral/intravenous steroids for pneumonia or exacerbation of respiratory disease in the last 2 weeks.
- Subjects with severe complications such as cardiovascular disease, liver disease, renal disease, and neurological disease.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05188976
Start Date
December 1 2021
End Date
December 1 2024
Last Update
March 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Hospital Organization Minami Kyoto Hospital
Jōyō, Kyoto, Japan, 610-0113